Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 602 45 750.5 |
96 | EP file number | EAKZ | 07 11 5060.1 |
97 | EP publication number | EPN | 1854454 |
54 | Designation/title | TI | Verfahren zur Herstellung von amorphen Telmisartan |
51 | IPC main class | ICM (ICMV) | A61K 9/16 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/4184 (2006.01) |
22 | DE application date | DAT | Jan 16, 2002 |
96 | EP application date | EAT | Jan 16, 2002 |
43 | Date of first publication | OT | Nov 14, 2007 |
| Date of publication of grant | PET | Nov 6, 2013 |
71/73 | Applicant/owner | INH | Boehringer Ingelheim Pharma GmbH & Co. KG, 55218 Ingelheim, DE |
72 | Inventor | IN | Friedl, Thomas, Dr., 88416, OCHSENHAUSEN, DE; Schepky, Gottfried, Dr., 79312, EMMENDINGEN, DE |
| Address for service | | Boehringer Ingelheim Pharma GmbH & Co. KG, 55216 Ingelheim, DE |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001854454 Searchable text:
EP000001854454 Original document:
EP000001854454B1 Searchable text:
EP000001854454B1 |
43 | Date of first publication | EVT | Nov 14, 2007 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 18, 2022 (Show all update days)(Hide all update days)- Jan 18, 2022; Feb 2, 2021; Jan 30, 2020; Aug 12, 2019; Feb 9, 2019; Feb 1, 2019; Jan 30, 2018; Feb 2, 2017; Feb 10, 2016; Feb 3, 2016; May 9, 2015; Jan 31, 2015; Nov 20, 2014; Oct 16, 2014; Feb 11, 2014; Jan 31, 2014; Dec 24, 2013; Nov 7, 2013; Jan 31, 2013
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|